Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy

Yao Xu1, Chen Liang1, Ying Luo1

  • 1Institute of Biology and Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China.

Insights

GATA4 inhibits myocardin activity in cardiac hypertrophy through competitive binding, reduced acetylation, and increased phosphorylation. These mechanisms clarify GATA4 and myocardin roles in heart disease development.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Myocardin is a key regulator of cardiac hypertrophy.
  • GATA4 influences myocardin activity, but the precise molecular mechanisms are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which GATA4 inhibits myocardin activity during cardiac hypertrophy.

Main Methods:

  • Investigated competitive binding of GATA4 and SRF to myocardin.
  • Assessed the effect of GATA4 on myocardin acetylation via p300 interaction.
  • Examined GATA4-mediated phosphorylation of myocardin upon ERK pathway activation.

Main Results:

  • GATA4 overexpression competitively binds SRF, reducing myocardin-SRF-CarG box complex formation.
  • GATA4 inhibits myocardin-p300 interaction, leading to decreased myocardin acetylation.
  • GATA4 upregulates myocardin phosphorylation through the ERK pathway.

Conclusions:

  • GATA4 employs multiple molecular strategies to inhibit myocardin activity in cardiac hypertrophy.
  • These findings enhance understanding of GATA4 and myocardin roles in cardiac hypertrophy pathogenesis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.9K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.4K